Custers, E.; Vreeken, D.; Schuren, F.; van den Broek, T.J.; van Dongen, L.; Geenen, B.; de Blaauw, I.; Wiesmann, M.; Hazebroek, E.J.; Kleemann, R.;
et al. Impact of Microbiota and Metabolites on Intestinal Integrity and Inflammation in Severe Obesity. Pharmaceuticals 2024, 17, 918.
https://doi.org/10.3390/ph17070918
AMA Style
Custers E, Vreeken D, Schuren F, van den Broek TJ, van Dongen L, Geenen B, de Blaauw I, Wiesmann M, Hazebroek EJ, Kleemann R,
et al. Impact of Microbiota and Metabolites on Intestinal Integrity and Inflammation in Severe Obesity. Pharmaceuticals. 2024; 17(7):918.
https://doi.org/10.3390/ph17070918
Chicago/Turabian Style
Custers, Emma, Debby Vreeken, Frank Schuren, Tim J. van den Broek, Lieke van Dongen, Bram Geenen, Ivo de Blaauw, Maximilian Wiesmann, Eric J. Hazebroek, Robert Kleemann,
and et al. 2024. "Impact of Microbiota and Metabolites on Intestinal Integrity and Inflammation in Severe Obesity" Pharmaceuticals 17, no. 7: 918.
https://doi.org/10.3390/ph17070918
APA Style
Custers, E., Vreeken, D., Schuren, F., van den Broek, T. J., van Dongen, L., Geenen, B., de Blaauw, I., Wiesmann, M., Hazebroek, E. J., Kleemann, R., & Kiliaan, A. J.
(2024). Impact of Microbiota and Metabolites on Intestinal Integrity and Inflammation in Severe Obesity. Pharmaceuticals, 17(7), 918.
https://doi.org/10.3390/ph17070918